ICBio Clinical Research Pvt. Ltd.

ICBio Clinical Research Pvt. Ltd. has conducted over a thousand clinical research projects including BA/BE and Phase II–IV trials accepted by global regulatory agencies such as USFDA, EMA, TGA Australia, MHRA UK, Health Canada and others. The company’s facilities are DCGI/CDSCO approved with NABL-accredited labs supporting high-throughput bioanalytical work using state-of-the-art equipment. They have developed validated methods for over 150 molecules and maintain a large volunteer database to support rapid study execution. No proprietary drug assets or pivotal trial results are reported as they operate as a service provider CRO.